Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
GeniusRx ™ Expands its Digital Pharmacy Reach by Launching GeniusClinic™ and GeniusIQ™ to Provide Telehealth Services and Medication Price Transparency to Meet the Growing Consumer Demand for Accessible and Affordable Healthcare
GeniusRx ™, a next-generation digital pharmacy focused on improving patient outcomes by disrupting the way […]
Labcon Awarded $59.3 Million U.S Government Contract to Increase Domestic Production of Pipette Tips and Tubes
Labcon North America, the world’s leading manufacturer of Earth Friendly® laboratory disposables, announced today a $59.3 million contract […]
Obsidian Therapeutics Appoints Maria Fardis, Ph.D., to Board of Directors
Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, today announced the […]
Bio-Rad Launches its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics
Bio–Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic […]
NHS Opens Online Covid-19 Vaccination Bookings For 12-15 Year Olds
Parents will be able to book covid-19 vaccinations online for their 12-15 year old children […]
GTP Bioways Invests €12M in Two GMP Biopharmaceutical Production Units
GTP Bioways, a CDMO (Contract Development and Manufacturing Organization) specializing in the production of biotherapies […]
Austin L. Chiang, M.D., M.P.H. joins Medtronic as Chief Medical Officer for Gastrointestinal Business
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced Austin L. Chiang, M.D., M.P.H., […]
UK Government Secures Groundbreaking COVID-19 Antivirals
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government […]
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) […]
Leucid Bio Raises £11.5M in Series A Financing to Develop Next Generation of Innovative Chimeric Antigen Receptor T cell (CAR-T) Therapies
Leucid Bio (“Leucid” or the “Company”), a biotech company pioneering next-generation cell therapies for hard-to-treat […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more